{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:07:31Z","timestamp":1779365251105,"version":"3.53.0"},"reference-count":46,"publisher":"Japanese Association for Laboratory Animal Science","issue":"3","funder":[{"DOI":"10.13039\/100009797","name":"Barrow Neurological Foundation","doi-asserted-by":"publisher","award":["3033227"],"award-info":[{"award-number":["3033227"]}],"id":[{"id":"10.13039\/100009797","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Seed fund","award":["02482323"],"award-info":[{"award-number":["02482323"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1538\/expanim.24-0118","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T18:12:35Z","timestamp":1742407955000},"page":"362-374","source":"Crossref","is-referenced-by-count":1,"title":["A novel early onset spinocerebellar ataxia 13 BAC mouse model with cerebellar atrophy, tremor, and ataxic gait"],"prefix":"10.1538","volume":"74","author":[{"given":"Junxiang","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Neurology, Icahn School of Medicine at Mount Sinai, 1468 Madison Ave, Annernberg 14-94 (Box 1137), New York, 10029, USA"},{"name":"Departments of Neurology, Barrow Neurological Institute, St. Joseph\u2019s Hospital and Medical Center, Dignity Health, 350 W Thomas Rd, Phoenix, Arizona 85013, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerelyn A.","family":"Nick","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, University of Florida, 1149 Newell Dr.Gainesville, Florida 32610,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Khare","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, University of Florida, 1149 Newell Dr.Gainesville, Florida 32610,USA"},{"name":"Oxford PharmaGenesis Inc, 103 Foulk Rd STE 202,Wilmington, Delaware 19803 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi E.","family":"Kloefkorn","sequence":"additional","affiliation":[{"name":"School of Chemical, Biological and Environmental Engineering, Oregon State University, 105 SW 26th St #116, Corvallis, Oregon, 97331, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Icahn School of Medicine at Mount Sinai, 1468 Madison Ave, Annernberg 14-94 (Box 1137), New York, 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Icahn School of Medicine at Mount Sinai, 1468 Madison Ave, Annernberg 14-94 (Box 1137), New York, 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"White","sequence":"additional","affiliation":[{"name":"Departments of Neurology, Barrow Neurological Institute, St. Joseph\u2019s Hospital and Medical Center, Dignity Health, 350 W Thomas Rd, Phoenix, Arizona 85013, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Resnick","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, University of Florida, 1200 Newell Drive, Florida 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle D.","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of Florida, PO Box 116131, Gainesville, Florida 32611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry S.","family":"Nick","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, University of Florida, 1149 Newell Dr.Gainesville, Florida 32610,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Waters","sequence":"additional","affiliation":[{"name":"Department of Neurology, Icahn School of Medicine at Mount Sinai, 1468 Madison Ave, Annernberg 14-94 (Box 1137), New York, 10029, USA"},{"name":"Departments of Neurology, Barrow Neurological Institute, St. Joseph\u2019s Hospital and Medical Center, Dignity Health, 350 W Thomas Rd, Phoenix, Arizona 85013, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Waters MF, Minassian NA, Stevanin G, Figueroa KP, Bannister JP, Nolte D, et al. Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Nat Genet.  2006;  38: 447\u2013451.","DOI":"10.1038\/ng1758"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Waters MF, Fee D, Figueroa KP, Nolte D, M\u00fcller U, Advincula J, et al. An autosomal dominant ataxia maps to 19q13: Allelic heterogeneity of SCA13 or novel locus? Neurology.  2005;  65: 1111\u20131113.","DOI":"10.1212\/01.wnl.0000177490.05162.41"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kaczmarek LK, Zhang Y. Kv3 Channels: Enablers of rapid firing, neurotransmitter release, and neuronal endurance. Physiol Rev.  2017;  97: 1431\u20131468.","DOI":"10.1152\/physrev.00002.2017"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Montaut S, Apartis E, Chanson JB, Ewenczyk C, Renaud M, Guissart C, et al. SCA13 causes dominantly inherited non-progressive myoclonus ataxia. Parkinsonism Relat Disord.  2017;  38: 80\u201384.","DOI":"10.1016\/j.parkreldis.2017.02.012"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers.  2019;  5: 24.","DOI":"10.1038\/s41572-019-0074-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Herman-Bert A, Stevanin G, Netter JC, Rascol O, Brassat D, Calvas P, et al. Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation. Am J Hum Genet.  2000;  67: 229\u2013235.","DOI":"10.1086\/302958"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Stevanin G, Durr A, Benammar N, Brice A. Spinocerebellar ataxia with mental retardation (SCA13). Cerebellum.  2005;  4: 43\u201346.","DOI":"10.1080\/14734220510007923"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Figueroa KP, Minassian NA, Stevanin G, Waters M, Garibyan V, Forlani S, et al. KCNC3: phenotype, mutations, channel biophysics-a study of 260 familial ataxia patients. Hum Mutat.  2010;  31: 191\u2013196.","DOI":"10.1002\/humu.21165"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Duarri A, Nibbeling EA, Fokkens MR, Meijer M, Boerrigter M, Verschuuren-Bemelmans CC, et al. Functional analysis helps to define KCNC3 mutational spectrum in Dutch ataxia cases. PLoS One.  2015;  10: e0116599.","DOI":"10.1371\/journal.pone.0116599"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Khare S, Nick JA, Zhang Y, Galeano K, Butler B, Khoshbouei H, et al. A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking. PLoS One.  2017;  12: e0173565.","DOI":"10.1371\/journal.pone.0173565"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chang SY, Zagha E, Kwon ES, Ozaita A, Bobik M, Martone ME, et al. Distribution of Kv3.3 potassium channel subunits in distinct neuronal populations of mouse brain. J Comp Neurol.  2007;  502: 953\u2013972.","DOI":"10.1002\/cne.21353"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sacco T, De Luca A, Tempia F. Properties and expression of Kv3 channels in cerebellar Purkinje cells. Mol Cell Neurosci.  2006;  33: 170\u2013179.","DOI":"10.1016\/j.mcn.2006.07.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Namikawa K, Dorigo A, Zagrebelsky M, Russo G, Kirmann T, Fahr W, et al. Modeling neurodegenerative spinocerebellar ataxia type 13 in zebrafish using a purkinje neuron specific tunable coexpression system. J Neurosci.  2019;  39: 3948\u20133969.","DOI":"10.1523\/JNEUROSCI.1862-18.2019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gallego-Iradi C, Bickford JS, Khare S, Hall A, Nick JA, Salmasinia D, et al. KCNC3(R420H), a K(+) channel mutation causative in spinocerebellar ataxia 13 displays aberrant intracellular trafficking. Neurobiol Dis.  2014;  71: 270\u2013279.","DOI":"10.1016\/j.nbd.2014.08.020"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Espinosa F, McMahon A, Chan E, Wang S, Ho CS, Heintz N, et al. Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3. J Neurosci.  2001;  21: 6657\u20136665.","DOI":"10.1523\/JNEUROSCI.21-17-06657.2001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zhang Y, Varela L, Szigeti-Buck K, Williams A, Stoiljkovic M, \u0160estan-Pe\u0161a M, et al. Cerebellar Kv3.3 potassium channels activate TANK-binding kinase 1 to regulate trafficking of the cell survival protein Hax-1. Nat Commun.  2021;  12: 1731.","DOI":"10.1038\/s41467-021-22003-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem.  2009;  55: 611\u2013622.","DOI":"10.1373\/clinchem.2008.112797"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Shattuck DW, Leahy RM. BrainSuite: an automated cortical surface identification tool. Med Image Anal.  2002;  6: 129\u2013142.","DOI":"10.1016\/S1361-8415(02)00054-3"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sandor S, Leahy R. Surface-based labeling of cortical anatomy using a deformable atlas. IEEE Trans Med Imaging.  1997;  16: 41\u201354.","DOI":"10.1109\/42.552054"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hedrick TL. Software techniques for two- and three-dimensional kinematic measurements of biological and biomimetic systems. Bioinspir Biomim.  2008;  3: 034001.","DOI":"10.1088\/1748-3182\/3\/3\/034001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jacobs BY, Kloefkorn HE, Allen KD. Gait analysis methods for rodent models of osteoarthritis. Curr Pain Headache Rep.  2014;  18: 456.","DOI":"10.1007\/s11916-014-0456-x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kloefkorn HE, Jacobs BY, Loye AM, Allen KD. Spatiotemporal gait compensations following medial collateral ligament and medial meniscus injury in the rat: correlating gait patterns to joint damage. Arthritis Res Ther.  2015;  17: 287.","DOI":"10.1186\/s13075-015-0791-2"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Xia G, McFarland KN, Wang K, Sarkar PS, Yachnis AT, Ashizawa T. Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10. J Neurol Neurosurg Psychiatry.  2013;  84: 1409\u20131411.","DOI":"10.1136\/jnnp-2013-305080"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ishida Y, Kawakami H, Kitajima H, Nishiyama A, Sasai Y, Inoue H, et al. Vulnerability of purkinje cells generated from spinocerebellar ataxia type 6 patient-derived iPSCs. Cell Rep.  2017;  18: 1075\u20131076.","DOI":"10.1016\/j.celrep.2017.01.012"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Vig PJ, Fratkin JD, Desaiah D, Currier RD, Subramony SH. Decreased parvalbumin immunoreactivity in surviving Purkinje cells of patients with spinocerebellar ataxia-1. Neurology.  1996;  47: 249\u2013253.","DOI":"10.1212\/WNL.47.1.249"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Edamakanti CR, Mohan V, Opal P. Reactive Bergmann glia play a central role in spinocerebellar ataxia inflammation via the JNK pathway. J Neuroinflammation.  2023;  20: 126.","DOI":"10.1186\/s12974-023-02801-1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. V\u00e1zquez-Mojena Y, Rodr\u00edguez-C\u00f3rdova Y, Dominguez-Barrios Y, Le\u00f3n-Arcia K, Miranda-Becerra D, Gonzalez-Zaldivar Y, et al. Peripheral inflammation links with the severity of clinical phenotype in spinocerebellar ataxia 2. Mov Disord.  2023;  38: 880\u2013885.","DOI":"10.1002\/mds.29359"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Evert BO, Vogt IR, Kindermann C, Ozimek L, de Vos RA, Brunt ER, et al. Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J Neurosci.  2001;  21: 5389\u20135396.","DOI":"10.1523\/JNEUROSCI.21-15-05389.2001"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Aikawa T, Mogushi K, Iijima-Tsutsui K, Ishikawa K, Sakurai M, Tanaka H, et al. Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model. Hum Mol Genet.  2015;  24: 4780\u20134791.","DOI":"10.1093\/hmg\/ddv202"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Hu YS, Do J, Edamakanti CR, Kini AR, Martina M, Stupp SI, et al. Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1. Brain.  2019;  142: 312\u2013321.","DOI":"10.1093\/brain\/awy328"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Elble RJ. Essential tremor frequency decreases with time. Neurology.  2000;  55: 1547\u20131551.","DOI":"10.1212\/WNL.55.10.1547"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lee HJ, Lee WW, Kim SK, Park H, Jeon HS, Kim HB, et al. Tremor frequency characteristics in Parkinson\u2019s disease under resting-state and stress-state conditions. J Neurol Sci.  2016;  362: 272\u2013277.","DOI":"10.1016\/j.jns.2016.01.058"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Cvetanovic M, Ingram M, Orr H, Opal P. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1. Neuroscience.  2015;  289: 289\u2013299.","DOI":"10.1016\/j.neuroscience.2015.01.003"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Toyoshima T, Yamagami S, Ahmed BY, Jin L, Miyamoto O, Itano T, et al. Expression of calbindin-D28K by reactive astrocytes in gerbil hippocampus after ischaemia. Neuroreport.  1996;  7: 2087\u20132091.","DOI":"10.1097\/00001756-199609020-00006"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Berman NE, Yong C, Raghavan R, Raymond LA, Joag SV, Narayan O, et al. Neurovirulent simian immunodeficiency virus induces calbindin-D-28K in astrocytes. Mol Chem Neuropathol.  1998;  34: 25\u201338.","DOI":"10.1007\/BF02815134"},{"key":"36","first-page":"1045","volume":"129","year":"2004","unstructured":"36. Kofuji P, Newman EA. Potassium buffering in the central nervous system. Neuroscience.  2004;  129: 1045\u20131056.","journal-title":"Neuroscience","ISSN":"https:\/\/id.crossref.org\/issn\/0306-4522","issn-type":"print"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Meera P, Pulst SM, Otis TS. Cellular and circuit mechanisms underlying spinocerebellar ataxias. J Physiol.  2016;  594: 4653\u20134660.","DOI":"10.1113\/JP271897"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Hansen ST, Meera P, Otis TS, Pulst SM. Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2. Hum Mol Genet.  2013;  22: 271\u2013283.","DOI":"10.1093\/hmg\/dds427"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Kasumu AW, Hougaard C, Rode F, Jacobsen TA, Sabatier JM, Eriksen BL, et al. Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2. Chem Biol.  2012;  19: 1340\u20131353.","DOI":"10.1016\/j.chembiol.2012.07.013"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Hourez R, Servais L, Orduz D, Gall D, Millard I, de Kerchove d\u2019Exaerde A, et al. Aminopyridines correct early dysfunction and delay neurodegeneration in a mouse model of spinocerebellar ataxia type 1. J Neurosci.  2011;  31: 11795\u201311807.","DOI":"10.1523\/JNEUROSCI.0905-11.2011"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Shakkottai VG, do Carmo Costa M, Dell\u2019Orco JM, Sankaranarayanan A, Wulff H, Paulson HL. Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3. J Neurosci.  2011;  31: 13002\u201313014.","DOI":"10.1523\/JNEUROSCI.2789-11.2011"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Perkins EM, Clarkson YL, Sabatier N, Longhurst DM, Millward CP, Jack J, et al. Loss of beta-III spectrin leads to Purkinje cell dysfunction recapitulating the behavior and neuropathology of spinocerebellar ataxia type 5 in humans. J Neurosci.  2010;  30: 4857\u20134867.","DOI":"10.1523\/JNEUROSCI.6065-09.2010"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Mark MD, Krause M, Boele HJ, Kruse W, Pollok S, Kuner T, et al. Spinocerebellar ataxia type 6 protein aggregates cause deficits in motor learning and cerebellar plasticity. J Neurosci.  2015;  35: 8882\u20138895.","DOI":"10.1523\/JNEUROSCI.0891-15.2015"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Irie T, Matsuzaki Y, Sekino Y, Hirai H. Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells. J Physiol.  2014;  592: 229\u2013247.","DOI":"10.1113\/jphysiol.2013.264309"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. McMahon A, Fowler SC, Perney TM, Akemann W, Kn\u00f6pfel T, Joho RH. Allele-dependent changes of olivocerebellar circuit properties in the absence of the voltage-gated potassium channels Kv3.1 and Kv3.3. Eur J Neurosci.  2004;  19: 3317\u20133327.","DOI":"10.1111\/j.0953-816X.2004.03385.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Minassian NA, Lin MC, Papazian DM. Altered Kv3.3 channel gating in early-onset spinocerebellar ataxia type 13. J Physiol.  2012;  590: 1599\u20131614.","DOI":"10.1113\/jphysiol.2012.228205"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/74\/3\/74_24-0118\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T03:50:09Z","timestamp":1752292209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/74\/3\/74_24-0118\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.24-0118","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"24-0118"}}